Clinical Trial Update: MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

An update on the Phase 1/2 trial of MLN2704 in metastatic androgen-independent prostate cancer, with the study listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• MLN2704

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Prostatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED